View ValuationVext Science 将来の成長Future 基準チェック /46Vext Scienceは、112.8%と14.2%でそれぞれ年率112.8%で利益と収益が成長すると予測される一方、EPSはgrowで103.3%年率。主要情報112.8%収益成長率103.25%EPS成長率Pharmaceuticals 収益成長14.5%収益成長率14.2%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日22 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 15Vext Science, Inc. to Report Q1, 2026 Results on May 21, 2026Vext Science, Inc. announced that they will report Q1, 2026 results Pre-Market on May 21, 2026お知らせ • Mar 31Vext Science, Inc. to Report Q4, 2025 Results on Apr 23, 2026Vext Science, Inc. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Apr 23, 2026お知らせ • Nov 11Vext Science, Inc. to Report Q3, 2025 Results on Nov 20, 2025Vext Science, Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 20, 2025お知らせ • Oct 13Vext Science, Inc., Annual General Meeting, Dec 11, 2025Vext Science, Inc., Annual General Meeting, Dec 11, 2025.お知らせ • Aug 11Vext Science, Inc. to Report Q2, 2025 Results on Aug 20, 2025Vext Science, Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 20, 2025お知らせ • May 13Vext Science, Inc. to Report Q1, 2025 Results on May 21, 2025Vext Science, Inc. announced that they will report Q1, 2025 results Pre-Market on May 21, 2025お知らせ • Apr 01Vext Science, Inc. (CNSX:VEXT) acquired the remaining 50% stake in Vapen Kentucky, LLC from Emerald Point Hemp, LLC.Vext Science, Inc. (CNSX:VEXT) acquired the remaining 50% stake in Vapen Kentucky, LLC from Emerald Point Hemp, LLC on March 26, 2025. Vext Science utilize a non-cash consideration in the transaction. For the period end date December 31, 2024, Vapen Kentucky, LLC reported $46.3 million revenue and $3.3 million net assets based on the equity accounted investment of Vext Science. Vext Science, Inc. (CNSX:VEXT) completed the acquisition of the remaining 50% stake in Vapen Kentucky, LLC from Emerald Point Hemp, LLC on March 26, 2025.お知らせ • Mar 20Vext Science, Inc. to Report Q4, 2024 Results on Mar 31, 2025Vext Science, Inc. announced that they will report Q4, 2024 results at 9:30 AM, US Eastern Standard Time on Mar 31, 2025お知らせ • Nov 07Vext Science, Inc. to Report Q3, 2024 Results on Nov 21, 2024Vext Science, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 21, 2024お知らせ • Oct 15Vext Science, Inc., Annual General Meeting, Dec 13, 2024Vext Science, Inc., Annual General Meeting, Dec 13, 2024.お知らせ • Aug 09Vext Science, Inc. to Report Q2, 2024 Results on Aug 20, 2024Vext Science, Inc. announced that they will report Q2, 2024 results at 9:30 AM, US Eastern Standard Time on Aug 20, 2024お知らせ • May 26Vext Science, Inc. to Report Q1, 2024 Results on May 29, 2024Vext Science, Inc. announced that they will report Q1, 2024 results Pre-Market on May 29, 2024お知らせ • Apr 16Vext Science, Inc. to Report Q4, 2023 Results on Apr 25, 2024Vext Science, Inc. announced that they will report Q4, 2023 results at 9:30 AM, US Eastern Standard Time on Apr 25, 2024お知らせ • Jan 17Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive RoleVext Science, Inc. announced that Jason Thai Nguyen has transitioned out of his executive positions with the Company, including resigning from all positions with the Company's subsidiaries and affiliates. Mr. Nguyen will continue to serve the Company through his position as a director of the Company and Chairman of the board of directors.お知らせ • Nov 22Vext Science, Inc. to Report Q3, 2023 Results on Nov 28, 2023Vext Science, Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 28, 2023お知らせ • Oct 14Vext Science, Inc., Annual General Meeting, Dec 15, 2023Vext Science, Inc., Annual General Meeting, Dec 15, 2023.お知らせ • Oct 13Vext Science, Inc. announced that it has received $11.5 million in funding from LLF Financial S.A.On October 12, 2023, Vext Science, Inc. closed the transaction. The company has now issued 67,647,058 common shares at a price of $0.17 per share for the gross proceeds of $11,500,000. In connection with the offering, the company has paid a cash finder's fee to certain registered dealers consisting of approximately $3,285. The transaction included participation from Mark Opzoomer, Trevor Smith and Sopica Special Opportunities Fund Limited managed by LLF Financial S.A. for 42,798,529 shares. Sopica Special Opportunities Fund Limited purchased 41,176,470 subordinate voting shares for $7,000,000 and its stake is increased by 21.56% (from 13.00% to 34.56%) on a non-diluted basis. Immediately prior to the Private Placement, the Acquirors beneficially owned or otherwise exercised control or direction over 10,726,849 Subordinate Voting Shares, 4,303,182 warrants to purchase Subordinate Voting Shares and 112,486 Class A common shares, representing approximately 26.79% of the issued and outstanding Subordinate Voting Shares. As a result of the Private Placement, the Acquirors beneficially own or otherwise exercise control or direction over 51,903,319 Subordinate Voting Shares, 4,303,182 Warrants and 112,486 Multiple Voting Shares, representing approximately 40.70% of the issued and outstanding Subordinate Voting Shares as at October 12, 2023.お知らせ • Aug 18Vext Science, Inc. to Report Q2, 2023 Results on Aug 23, 2023Vext Science, Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 23, 2023お知らせ • Aug 11+ 1 more updateVext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023Vext Science, Inc. reported that Stephan Bankosz has resigned as CFO and Corporate Secretary of the Company effective August 25, 2023 to pursue other opportunities. Vext will appoint experienced financial executive and operator Trevor Smith as CFO. In the coming weeks Mr. Bankosz will assist with the transition of duties to Mr. Smith, which is expected to be completed after Vext has reported its second quarter 2023 earnings. Nalee Pham, the Company's Chief of Staff and a director of the Company's wholly-owned operating subsidiary Herbal Wellness Center, LLC has been appointed Corporate Secretary.お知らせ • May 16Vext Science, Inc. to Report Q1, 2023 Results on May 25, 2023Vext Science, Inc. announced that they will report Q1, 2023 results Pre-Market on May 25, 2023業績と収益の成長予測OTCPK:VEXT.F - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202874-22014112/31/20276921815212/31/202654-291113/31/202652-16710N/A12/31/202551-18812N/A9/30/202548-17913N/A6/30/202544-17911N/A3/31/202539-1946N/A12/31/202436-2223N/A9/30/202434-8-20N/A6/30/202433-7-10N/A3/31/202434-224N/A12/31/202335424N/A9/30/202335546N/A6/30/202334705N/A3/31/2023349-23N/A12/31/20223511-36N/A9/30/2022376-38N/A6/30/2022386011N/A3/31/2022396-1012N/A12/31/2021375-811N/A9/30/2021345-98N/A6/30/2021335-88N/A3/31/202130426N/A12/31/2020252-13N/A9/30/2020220-22N/A6/30/2020200-61N/A3/31/2020200-60N/A12/31/2019223N/A0N/A9/30/2019234N/A-1N/A6/30/2019235N/A-1N/A3/31/2019214N/A0N/A12/31/2018184N/A2N/A12/31/2017154N/A2N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: VEXT.Fは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 3.5% ) よりも高い成長率であると考えられます。収益対市場: VEXT.F今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。高成長収益: VEXT.F今後 3 年以内に収益を上げることが予想されます。収益対市場: VEXT.Fの収益 ( 14.2% ) US市場 ( 11.7% ) よりも速いペースで成長すると予測されています。高い収益成長: VEXT.Fの収益 ( 14.2% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: VEXT.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 10:07終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Vext Science, Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Matt BottomleyCanaccord GenuityShaan MirCanaccord GenuityNeal GilmerHaywood Securities Inc.4 その他のアナリストを表示
お知らせ • May 15Vext Science, Inc. to Report Q1, 2026 Results on May 21, 2026Vext Science, Inc. announced that they will report Q1, 2026 results Pre-Market on May 21, 2026
お知らせ • Mar 31Vext Science, Inc. to Report Q4, 2025 Results on Apr 23, 2026Vext Science, Inc. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Apr 23, 2026
お知らせ • Nov 11Vext Science, Inc. to Report Q3, 2025 Results on Nov 20, 2025Vext Science, Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 20, 2025
お知らせ • Oct 13Vext Science, Inc., Annual General Meeting, Dec 11, 2025Vext Science, Inc., Annual General Meeting, Dec 11, 2025.
お知らせ • Aug 11Vext Science, Inc. to Report Q2, 2025 Results on Aug 20, 2025Vext Science, Inc. announced that they will report Q2, 2025 results Pre-Market on Aug 20, 2025
お知らせ • May 13Vext Science, Inc. to Report Q1, 2025 Results on May 21, 2025Vext Science, Inc. announced that they will report Q1, 2025 results Pre-Market on May 21, 2025
お知らせ • Apr 01Vext Science, Inc. (CNSX:VEXT) acquired the remaining 50% stake in Vapen Kentucky, LLC from Emerald Point Hemp, LLC.Vext Science, Inc. (CNSX:VEXT) acquired the remaining 50% stake in Vapen Kentucky, LLC from Emerald Point Hemp, LLC on March 26, 2025. Vext Science utilize a non-cash consideration in the transaction. For the period end date December 31, 2024, Vapen Kentucky, LLC reported $46.3 million revenue and $3.3 million net assets based on the equity accounted investment of Vext Science. Vext Science, Inc. (CNSX:VEXT) completed the acquisition of the remaining 50% stake in Vapen Kentucky, LLC from Emerald Point Hemp, LLC on March 26, 2025.
お知らせ • Mar 20Vext Science, Inc. to Report Q4, 2024 Results on Mar 31, 2025Vext Science, Inc. announced that they will report Q4, 2024 results at 9:30 AM, US Eastern Standard Time on Mar 31, 2025
お知らせ • Nov 07Vext Science, Inc. to Report Q3, 2024 Results on Nov 21, 2024Vext Science, Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 21, 2024
お知らせ • Oct 15Vext Science, Inc., Annual General Meeting, Dec 13, 2024Vext Science, Inc., Annual General Meeting, Dec 13, 2024.
お知らせ • Aug 09Vext Science, Inc. to Report Q2, 2024 Results on Aug 20, 2024Vext Science, Inc. announced that they will report Q2, 2024 results at 9:30 AM, US Eastern Standard Time on Aug 20, 2024
お知らせ • May 26Vext Science, Inc. to Report Q1, 2024 Results on May 29, 2024Vext Science, Inc. announced that they will report Q1, 2024 results Pre-Market on May 29, 2024
お知らせ • Apr 16Vext Science, Inc. to Report Q4, 2023 Results on Apr 25, 2024Vext Science, Inc. announced that they will report Q4, 2023 results at 9:30 AM, US Eastern Standard Time on Apr 25, 2024
お知らせ • Jan 17Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive RoleVext Science, Inc. announced that Jason Thai Nguyen has transitioned out of his executive positions with the Company, including resigning from all positions with the Company's subsidiaries and affiliates. Mr. Nguyen will continue to serve the Company through his position as a director of the Company and Chairman of the board of directors.
お知らせ • Nov 22Vext Science, Inc. to Report Q3, 2023 Results on Nov 28, 2023Vext Science, Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 28, 2023
お知らせ • Oct 14Vext Science, Inc., Annual General Meeting, Dec 15, 2023Vext Science, Inc., Annual General Meeting, Dec 15, 2023.
お知らせ • Oct 13Vext Science, Inc. announced that it has received $11.5 million in funding from LLF Financial S.A.On October 12, 2023, Vext Science, Inc. closed the transaction. The company has now issued 67,647,058 common shares at a price of $0.17 per share for the gross proceeds of $11,500,000. In connection with the offering, the company has paid a cash finder's fee to certain registered dealers consisting of approximately $3,285. The transaction included participation from Mark Opzoomer, Trevor Smith and Sopica Special Opportunities Fund Limited managed by LLF Financial S.A. for 42,798,529 shares. Sopica Special Opportunities Fund Limited purchased 41,176,470 subordinate voting shares for $7,000,000 and its stake is increased by 21.56% (from 13.00% to 34.56%) on a non-diluted basis. Immediately prior to the Private Placement, the Acquirors beneficially owned or otherwise exercised control or direction over 10,726,849 Subordinate Voting Shares, 4,303,182 warrants to purchase Subordinate Voting Shares and 112,486 Class A common shares, representing approximately 26.79% of the issued and outstanding Subordinate Voting Shares. As a result of the Private Placement, the Acquirors beneficially own or otherwise exercise control or direction over 51,903,319 Subordinate Voting Shares, 4,303,182 Warrants and 112,486 Multiple Voting Shares, representing approximately 40.70% of the issued and outstanding Subordinate Voting Shares as at October 12, 2023.
お知らせ • Aug 18Vext Science, Inc. to Report Q2, 2023 Results on Aug 23, 2023Vext Science, Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 23, 2023
お知らせ • Aug 11+ 1 more updateVext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023Vext Science, Inc. reported that Stephan Bankosz has resigned as CFO and Corporate Secretary of the Company effective August 25, 2023 to pursue other opportunities. Vext will appoint experienced financial executive and operator Trevor Smith as CFO. In the coming weeks Mr. Bankosz will assist with the transition of duties to Mr. Smith, which is expected to be completed after Vext has reported its second quarter 2023 earnings. Nalee Pham, the Company's Chief of Staff and a director of the Company's wholly-owned operating subsidiary Herbal Wellness Center, LLC has been appointed Corporate Secretary.
お知らせ • May 16Vext Science, Inc. to Report Q1, 2023 Results on May 25, 2023Vext Science, Inc. announced that they will report Q1, 2023 results Pre-Market on May 25, 2023